Nasim Ebrahimi

1.2k total citations
44 papers, 825 citations indexed

About

Nasim Ebrahimi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Nasim Ebrahimi has authored 44 papers receiving a total of 825 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 12 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Nasim Ebrahimi's work include Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (4 papers). Nasim Ebrahimi is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (4 papers). Nasim Ebrahimi collaborates with scholars based in Iran, United States and South Africa. Nasim Ebrahimi's co-authors include Michael R. Hamblin, Fatemeh Rezaei‐Tazangi, Samaneh Adelian, Amir Reza Aref, Roya Khorram, Amir Reza Aref, Amirhossein Ahmadi, Sajjad Ghorghanlu, Nasser Hashemi Goradel and Babak Negahdari and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the New York Academy of Sciences and British Journal of Pharmacology.

In The Last Decade

Nasim Ebrahimi

43 papers receiving 818 citations

Peers

Nasim Ebrahimi

ONCOL

IMMUN

GENET

Wenhao Guo China

Saroj K. Basak United States

Chi‐Chen Fan Taiwan

Ruting Xie China

Zuzana Kozovská Slovakia

Sina Taefehshokr Iran

Zhijian Xiao China

Shiran Shapira Israel

Yang Guo China

Wenhao Guo China

Nasim Ebrahimi

500 ×1.1

237 ×1.1

ONCOL

246 ×1.2

88 ×0.6

IMMUN

36 ×0.4

GENET

Citations per year, relative to Nasim Ebrahimi Nasim Ebrahimi (= 1×) peers Wenhao Guo

Countries citing papers authored by Nasim Ebrahimi

Since Specialization

Citations

This map shows the geographic impact of Nasim Ebrahimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasim Ebrahimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasim Ebrahimi more than expected).

Fields of papers citing papers by Nasim Ebrahimi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nasim Ebrahimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasim Ebrahimi. The network helps show where Nasim Ebrahimi may publish in the future.

Co-authorship network of co-authors of Nasim Ebrahimi

This figure shows the co-authorship network connecting the top 25 collaborators of Nasim Ebrahimi. A scholar is included among the top collaborators of Nasim Ebrahimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasim Ebrahimi. Nasim Ebrahimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nazari, Ahmad, et al.. (2024). New Emerging Therapeutic Strategies Based on Manipulation of the Redox Regulation Against Therapy Resistance in Cancer. Antioxidants and Redox Signaling. ars20230491–ars20230491. 3 indexed citations

Ebrahimi, Nasim, Atena Mansouri, Samaneh Adelian, et al.. (2024). Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy. Cellular and Molecular Life Sciences. 81(1). 106–106. 45 indexed citations

Ebrahimi, Nasim, Fatemeh Rezaei‐Tazangi, Payam Baziyar, et al.. (2023). The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma. Environmental Research. 228. 115914–115914. 12 indexed citations

Ebrahimi, Nasim, Samaneh Adelian, Fatemeh Rezaei‐Tazangi, et al.. (2023). Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance. Critical Reviews in Oncology/Hematology. 182. 103920–103920. 61 indexed citations

Ebrahimi, Nasim, Roya Khorram, Fatemeh Rezaei‐Tazangi, et al.. (2023). Receptor tyrosine kinase inhibitors in cancer. Cellular and Molecular Life Sciences. 80(4). 104–104. 78 indexed citations

Ebrahimi, Nasim, Ahmad Nazari, Fatemeh Rezaei‐Tazangi, et al.. (2023). Nano-scale delivery systems for siRNA delivery in cancer therapy: New era of gene therapy empowered by nanotechnology. Environmental Research. 239(Pt 2). 117263–117263. 45 indexed citations

Shoja, Saeed, et al.. (2023). Characterization of genotypes and antimicrobial resistance profiles of clinical isolates of Shigella from patients in the southern region of Iran. European journal of medical research. 28(1). 3 indexed citations

Ebrahimi, Nasim, Fatemeh Rezaei‐Tazangi, Samaneh Adelian, et al.. (2022). Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer. Cellular and Molecular Life Sciences. 79(11). 572–572. 24 indexed citations

Ebrahimi, Nasim, et al.. (2022). Crosstalk between lncRNAs in the apoptotic pathway and therapeutic targets in cancer. Cytokine & Growth Factor Reviews. 65. 61–74. 26 indexed citations

10.

Ebrahimi, Nasim, et al.. (2022). Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy. Cytokine & Growth Factor Reviews. 64. 33–45. 60 indexed citations

11.

Amirmahani, Farzane, et al.. (2021). Long Noncoding RNAs CAT2064 and CAT2042 may Function as Diagnostic Biomarkers for Prostate Cancer by Affecting Target MicrorRNAs. Indian Journal of Clinical Biochemistry. 39(3). 322–330. 6 indexed citations

12.

Goradel, Nasser Hashemi, Arash Arashkia, Nasim Ebrahimi, et al.. (2021). Virus against virus: strategies for using adenovirus vectors in the treatment of HPV-induced cervical cancer. Acta Pharmacologica Sinica. 42(12). 1981–1990. 23 indexed citations

13.

Ebrahimi, Nasim, et al.. (2021). The potential application of organoids in breast cancer research and treatment. Human Genetics. 141(2). 193–208. 17 indexed citations

14.

Rostami, Soodabeh, et al.. (2021). Macrolide-resistance, capsular genotyping and associated factors of group B Streptococci colonized pregnant women in Isfahan, Iran. Iranian Journal of Microbiology. 13(2). 183–189. 5 indexed citations

15.

Ebrahimi, Nasim, et al.. (2021). Crosstalk between non-coding RNAs expression profile, drug resistance and immune response in breast cancer. Pharmacological Research. 176. 106041–106041. 25 indexed citations

16.

Goradel, Nasser Hashemi, Alexander T. Baker, Arash Arashkia, et al.. (2020). Oncolytic virotherapy: Challenges and solutions. Current Problems in Cancer. 45(1). 100639–100639. 79 indexed citations

17.

Ebrahimi, Nasim, et al.. (2016). Analysis of Genetic Variation of rs1542705 Marker in SMPD1 Gene Region as an Informative Marker for Molecular Diagnosis of Niemann-Pick Disease in Isfahan Population. SHILAP Revista de lepidopterología. 4 indexed citations

18.

Ebrahimi, Nasim, et al.. (2016). A Study on the Preferences of Parents of Patients with Thalassemia Major in Obtaining Health Information. SHILAP Revista de lepidopterología. 1 indexed citations

19.

Amin, Mansour, et al.. (2015). Oropharyngeal Colonization With Neisseria lactamica, Other Nonpathogenic Neisseria Species and Moraxella catarrhalis Among Young Healthy Children in Ahvaz, Iran. Jundishapur Journal of Microbiology. 8(3). e14813–e14813. 8 indexed citations

20.

Moosavian, Mojtaba, Saeed Shoja, Roohangiz Nashibi, et al.. (2014). Post Neurosurgical Meningitis due to Colistin Heteroresistant Acinetobacter baumannii. Jundishapur Journal of Microbiology. 7(8). e12287–e12287. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact